The Track IV will provide researchers from major pharmaceutical companies with key updates on important developments in the Protein/Peptide Vaccine and antibody field, You can deliver the current state of vaccine research and development on a global setting and discuss the latest challenges and problems facing the market. It will transform the way you will approach future research for the better. Registration Now!

Session 16: Protein and Peptide Vaccine Research and Development

Speaking Opportunities Available

This session will cover the following areas:

• Protein/ Peptide Vaccine Antigen Selection & Design
• Vaccine Delivery Methods / Adjuvants
• Prophylactic Vaccine Trials
• Vaccine Safety Evaluation
• Next Generation Vaccines
• Large Scale Production
• Investment for New Vaccine Products
• Commercial Opportunities with Vaccine Development
• R&D Collaborations in Vaccine Development
• Therapeutic Vaccine
• Prophylactic Vaccines
• Major Pediatric Vaccines
  • Pneumococcal Vaccines
  • Polio Vaccines
  • Varicella Vaccines
  • Meningitis Vaccines
  • Rotavirus Vaccines
  • DTP Vaccines
  • Measles, Mumps & Rubella (MMR) Vaccines
  • Tuberculosis Vaccines
• Major Adult/Travel & Therapeutic Vaccines
  • HIV Vaccines
  • Cancer Vaccines
  • Japanese Encephalitis Vaccines
  • Ebola Vaccines
  • Malaria Vaccines
  • Typhoid Vaccines
  • West Nile Vaccines
  • Hepatitis B Vaccines

  Or you can propose new topics to be covered from your expert opinion here!

Session 17: Outsourcing Antibody Development and Production

Speaking Opportunities Available

This session will cover the following topics:

• Monoclonal Antibody Technology
• Antibody Drug Development
• Specific Antibody Synthesis
• Improving Effector Functions Of Antibodies
• Antibody Therapeutics: Product Development, Market Trends, And Strategic Issues
• Antibody Diagnosis
• Therapies Sector Analysis Tool
• Antibody Manufacturing And Purification
• Purifying Any Antibodies Quickly And Efficiently
• Applications And Business Cases
• Novel Medicines For Multi-Resistant Bacteria And Emerging Viruses
• Immunogenicity
• Next Generation Of Antibody Drugs
• Engineering Therapeutics
• Antibody Aggregation
• Making, Financing & Outsourcing

  Or you can propose new topics to be covered from your expert opinion here!

Session 18: Protein/Peptide Structure Activity and Interaction（Part Ⅱ）

Speaking Opportunities Available

• Basic Researches on Protein and Peptide
• Relationship of Structure and Activity
• Analysis of Structure
• Experiment in Activity
• Relationship between Drug Discovery and Protein Structure
• New Approaches in Protien/Peptide Analysis

  Or you can propose new topics to be covered from your expert opinion here!